
Immunodiagnostic Systems Holdings PLC (“the Company”), a leading producer of diagnostic testing kits, announces that on 29 January 2010, 33,361 ordinary shares of 2p each in the Company (the “Ordinary Shares”) were allotted in a board meeting to satisfy an exercise of options. Additionally, at the same board meeting 26,648 Ordinary Shares were allotted to […]